Press Releases - all

Displaying 1 - 10 of 14 results
Collapse Filters

Click here for Archived Press Releases prior to 2016

Expand Filters         +
April 5, 2019

Fentanyl and heroin darknet vendors indicted

SACRAMENTO, Calif. — A Rancho Cordova woman was indicted on April 4, 2019, charged with distribution of fentanyl and oxycodone and other opioids as a result of a coordinated operation by the U.S. Attorney’s Office, the Federal Bureau of Investigation, Homeland Security Investigations, the Drug Enforcement Administration and the U.S.

February 7, 2019

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York,  announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for attempting to import heroin into the United States, engaging in narco-terrorism for the benefit of the Taliban, and attempting to engage in narco-terrorism for the benefit of the Haqqani Network.

November 2, 2018

DEA releases 2018 National Drug Threat Assessment

WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs.

August 28, 2018

DEA investigators seeking answers in small Tennessee town

CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry  into irregular patterns of pill purchases from drug distribution companies.  DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at each of the pharmacies in question. According to sales data, these pharmacies purchased nearly 1.5 million pills in 2017, a number not typically reflective of a rural area such as Clay County.

August 16, 2018

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases manufacturing quotas for the six most frequently misused opioids for 2019 by an average ten percent as compared to the 2018 amount.

July 11, 2018

Department of Justice announces regulatory steps to address opioid epidemic

WASHINGTON – The Department of Justice today announced the finalization of an April proposal to improve the Drug Enforcement Administration’s ability to control the diversion of dangerous drugs in the midst of the national opioid crisis. Announced in April by Attorney General Jeff Sessions, the final rule sent for publication today in the Federal Register establishes that DEA will take into consideration the extent that a drug is diverted for abuse when it sets its annual opioid production limits. 

DEA US Badge
United States Drug Enforcement Administration is an official site of the U.S. Department of Justice